BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19361412)

  • 1. [Colorectal cancer screening programme in France, role of the National Institute of Cancer].
    Viguier J; Nathan Mle Q
    Med Sci (Paris); 2009 Mar; 25 Spec No 1():45-52. PubMed ID: 19361412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. French colorectal cancer screening pilot programme: results of the first round.
    Goulard H; Boussac-Zarebska M; Ancelle-Park R; Bloch J
    J Med Screen; 2008; 15(3):143-8. PubMed ID: 18927097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004.
    Malila N; Anttila A; Hakama M
    J Med Screen; 2005; 12(1):28-32. PubMed ID: 15814016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
    Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P
    Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [French screening program of breast cancer. Results from 5 districts (1989-1994)].
    Séradour B; Allemand H; Schaffer P
    Bull Cancer; 1997 Aug; 84(8):822-8. PubMed ID: 9339188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
    Malila N; Oivanen T; Hakama M
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evidence-based planning: the case of mass screening for colorectal cancer in the Lazio region of Italy].
    Federici A; Borgia P; Guasticchi G
    Ann Ig; 2005; 17(4):313-22. PubMed ID: 16156391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based breast cancer screening: policy advice for a New Zealand screening programme. Breast Cancer Screening Policy Advisory Group.
    N Z Med J; 1998 Apr; 111(1064):138-42. PubMed ID: 9612474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations on population screening for colorectal cancer in New Zealand. Members of the National Health Committee Working Party on Population Screening for Colorectal Cancer.
    N Z Med J; 1999 Jan; 112(1080):4-6. PubMed ID: 10073156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Economic evaluation of the new national breast cancer screening programme in France: application to the Bouche-du-Rhone district].
    Giorgi R; Reynaud J; Wait S; Seradour B
    Bull Cancer; 2005 Nov; 92(11):995-1001. PubMed ID: 16316834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Breast, cervical and colo-rectal simultaneous mass screening program for women 50 to 69 years old in Isere].
    Garnier A; Exbrayat C; Marron J; Seigneurin D; Winckel P; Bolla M
    Sante Publique; 2000 May; 12 Spec No():59-69. PubMed ID: 10989629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for population colorectal cancer screening in New Zealand.
    Parry S; Richardson A; Green T; Marshall B; Bissett I; Bloomfield A; Chadwick V; Cunningham C; Findlay M; Greer B; McMenamin J; Strid J; Robertson G; Teague C
    N Z Med J; 2007 Jul; 120(1258):U2633. PubMed ID: 17653251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling future capacity needs and spending on colonoscopy in the English bowel cancer screening programme.
    Nnoaham KE; Lines C
    Gut; 2008 Sep; 57(9):1238-45. PubMed ID: 18441004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer screening in Singapore, with particular reference to breast, cervical and colorectal cancer screening.
    Yeoh KG; Chew L; Wang SC
    J Med Screen; 2006; 13 Suppl 1():S14-9. PubMed ID: 17227636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain).
    Peris M; Espinàs JA; Muñoz L; Navarro M; Binefa G; Borràs JM;
    J Med Screen; 2007; 14(2):81-6. PubMed ID: 17626707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colon cancer screening and surveillance controversies.
    Lieberman D
    Curr Opin Gastroenterol; 2009 Sep; 25(5):422-7. PubMed ID: 19465849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in screening for colorectal cancer--United States, 1997 and 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Mar; 50(9):162-6. PubMed ID: 11393486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.